LensGen, Inc. | Irvine, California
A biomimetic accommodating intraocular lens
News:   LENSGEN® Announces Presentations and SCIENTIFIC Papers AT ESCRS
              LensGen Updates on Juvene IOL, adds $15m to Series A
                  

---

Envision Diagnostics, Inc. | Los Angeles, California
Enabling precision medicine by unlocking oligonucleuotide therapeutics.
  News:  DTx Pharma Completes $10.6 Million Series A Financing

---

DTx Pharma. | San Diego, California
Enabling precision medicine by unlocking oligonucleuotide therapeutics.
News:  DTx Pharma Completes $10.6 Million Series A Financing

---

ONL Therapeutics, Inc. | Ann Arbor, Michigan
Pioneering an entirely new approach to preserving sight
News:   ONL Therapeutics Announces First Patient Treated in Phase I Study With ONL1204
               ONL Therapeutics Announces First-in-human Clinical Study With ONL1204
               ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 

---

Trefoil Therapeutics, Inc. | San Diego, California
Developing novel compounds to treat corneal dystrophies
News:  Trefoil Therapeutics Appoints Thomas M. Tremblay, RN BSN, Vice President,             Clinical Development
                  Trefoil Therapeutics Raises $5.2 Million Series 1 Financing 
                 

---

2C Tech Corporation, Inc. | Irvine, California
Quantum Dots to treat retinal disease 
Studies:  Library

---

  Qura, Inc. | Boston, Massachusetts
  Implantable intraocular pressure sensor 
  News:  Qura receives strategic investment from Santen Ventures

---

RetroSense Therapeutics, LLC | Irvine, California
(Acquired: Allergan) First in class optogenetics therapy to treat retinal diseases 
News:  Allergan Acquires Gene Therapy Company RetroSense Therapeutics 

---